Get Complete Access to the Redica Systems Platform
Please submit your email address and one of our team members will contact you shortly to answer all of your questions and get you started with the new Enforcement Analytics platform.
Enforcement Posts
Enforcement
FDA Issues 38-Page 483 to Solid Oral Dosage Manufacturer
Barbara W. Unger
February 23, 2021
Enforcement
OTC Skincare Firm Receives Warning Letter Due to CGMP Concerns
redica
January 13, 2021
Enforcement
FDA Warning Letters Weeks of 11/22/2020 & 12/1/2020: Water Leaks, Misleading Statements, & Adulteration
Barbara W. Unger
December 8, 2020
Enforcement
FDA Warning Letters Week Of 11/8/2020: Process Validation Failures
Barbara W. Unger
November 17, 2020
Enforcement
FDA Warning Letters Week Of 11/1/2020: Unapproved HTC/P, Hold Times, & FD&C Violations
Barbara W. Unger
November 10, 2020
Enforcement
FDA Warning Letters Week Of 10/25/2020: Cleaning Validation & Foreign Particles
Barbara W. Unger
November 3, 2020
Enforcement
FDA Warning Letters Week Of 10/18/2020: Misbranded Biologics & Pharmacy Ceases Operations
Barbara W. Unger
October 27, 2020
Enforcement
FDA Warning Letters Week Of 10/11/2020: Unauthorized Cell Therapy & Inadequate CAPAs
Barbara W. Unger
October 20, 2020
Enforcement
FDA Warning Letters Week Of 10/4/2020: Validation Failures & Medical Device Adverse Events
Barbara W. Unger
October 13, 2020
